KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsGoodwill & IntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Rigel Pharmaceuticals (RIGL) Retained Earnings (2016 - 2025)

Rigel Pharmaceuticals has reported Retained Earnings over the past 16 years, most recently at $181000.0 for Q4 2025.

  • Quarterly results put Retained Earnings at $181000.0 for Q4 2025, up 100.01% from a year ago — trailing twelve months through Dec 2025 was $181000.0 (up 100.01% YoY), and the annual figure for FY2025 was $181000.0, up 100.01%.
  • Retained Earnings for Q4 2025 was $181000.0 at Rigel Pharmaceuticals, up from -$1.3 billion in the prior quarter.
  • Over the last five years, Retained Earnings for RIGL hit a ceiling of $181000.0 in Q4 2025 and a floor of -$1.4 billion in Q1 2024.
  • Median Retained Earnings over the past 5 years was -$640.4 million (2021), compared with a mean of -$680.6 million.
  • Biggest five-year swings in Retained Earnings: tumbled 33097050.0% in 2021 and later surged 100.01% in 2025.
  • Rigel Pharmaceuticals' Retained Earnings stood at -$1.3 billion in 2021, then fell by 4.42% to -$1.4 billion in 2022, then surged by 100.0% to $8000.0 in 2023, then plummeted by 17375912.5% to -$1.4 billion in 2024, then surged by 100.01% to $181000.0 in 2025.
  • The last three reported values for Retained Earnings were $181000.0 (Q4 2025), -$1.3 billion (Q3 2025), and -$1.3 billion (Q2 2025) per Business Quant data.